Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Advaxis stock | $0.4942

Learn how to easily invest in Advaxis stock.

Advaxis Inc is a biotechnology business based in the US. Advaxis shares (ADXS) are listed on the NASDAQ and all prices are listed in US Dollars. Advaxis employs 17 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Advaxis

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADXS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Advaxis stock price (NASDAQ: ADXS)

Use our graph to track the performance of ADXS stocks over time.

Advaxis shares at a glance

Information last updated 2021-10-24.
Latest market close$0.49
52-week range$0.27 - $1.57
50-day moving average $0.50
200-day moving average $0.48
Wall St. target price$2.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.17

Buy Advaxis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Advaxis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Advaxis price performance over time

Historical closes compared with the close of $0.4942 from 2021-10-26

1 week (2021-10-16) N/A
1 month (2021-09-27) -4.22%
3 months (2021-07-27) 19.95%
6 months (2021-04-27) -3.66%
1 year (2020-10-27) 25.43%
2 years (2019-10-25) 63.43%
3 years (2018-10-26) 0.6199
5 years (2016-10-27) 7.87

Advaxis financials

Revenue TTM $3.2 million
Gross profit TTM $253,000
Return on assets TTM -25.86%
Return on equity TTM -49.85%
Profit margin 0%
Book value $0.30
Market capitalisation $68.2 million

TTM: trailing 12 months

Shorting Advaxis shares

There are currently 3.4 million Advaxis shares held short by investors – that's known as Advaxis's "short interest". This figure is 29.3% down from 4.8 million last month.

There are a few different ways that this level of interest in shorting Advaxis shares can be evaluated.

Advaxis's "short interest ratio" (SIR)

Advaxis's "short interest ratio" (SIR) is the quantity of Advaxis shares currently shorted divided by the average quantity of Advaxis shares traded daily (recently around 9.2 million). Advaxis's SIR currently stands at 0.37. In other words for every 100,000 Advaxis shares traded daily on the market, roughly 370 shares are currently held short.

However Advaxis's short interest can also be evaluated against the total number of Advaxis shares, or, against the total number of tradable Advaxis shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Advaxis's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Advaxis shares in existence, roughly 20 shares are currently held short) or 0.0235% of the tradable shares (for every 100,000 tradable Advaxis shares, roughly 24 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Advaxis.

Find out more about how you can short Advaxis stock.

Advaxis share dividends

We're not expecting Advaxis to pay a dividend over the next 12 months.

Have Advaxis's shares ever split?

Advaxis's shares were split on a 1:15 basis on 28 March 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Advaxis shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Advaxis shares which in turn could have impacted Advaxis's share price.

Advaxis share price volatility

Over the last 12 months, Advaxis's shares have ranged in value from as little as $0.272 up to $1.57. A popular way to gauge a stock's volatility is its "beta".

ADXS.US volatility(beta: 2.3)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Advaxis's is 2.3032. This would suggest that Advaxis's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Advaxis overview

Advaxis, Inc. , a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co. , Inc. ; OS Therapies, LLC; Aratana Therapeutics Inc.

Advaxis in the news

There are no recent company news

Frequently asked questions

What percentage of Advaxis is owned by insiders or institutions?
Currently 0.065% of Advaxis shares are held by insiders and 11.369% by institutions.
How many people work for Advaxis?
Latest data suggests 17 work at Advaxis.
When does the fiscal year end for Advaxis?
Advaxis's fiscal year ends in October.
Where is Advaxis based?
Advaxis's address is: 9 Deer Park Drive, Monmouth Junction, NJ, United States, 08852
What is Advaxis's ISIN number?
Advaxis's international securities identification number is: US0076243072
What is Advaxis's CUSIP number?
Advaxis's Committee on Uniform Securities Identification Procedures number is: 007624109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site